These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 7502902

  • 21. Cellular factors in the induction of mucosal immunity by oral immunization.
    Challacombe SJ.
    Adv Exp Med Biol; 1987; 216B():887-99. PubMed ID: 3501239
    [No Abstract] [Full Text] [Related]

  • 22. Immunization against the oral indigenous bacteria of the BALB/c mouse.
    Marcotte H, Rodrigue L, Gamache M, Lavoie MC.
    Adv Exp Med Biol; 1995; 371B():1173-6. PubMed ID: 7502778
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevention of infections of the respiratory tract using the oral application of antigens.
    Tischner H.
    Z Erkr Atmungsorgane; 1991; 176(2-3):131-7. PubMed ID: 1858413
    [No Abstract] [Full Text] [Related]

  • 26. Perturbation of mucosal immune defence mechanisms by bacterial IgA proteases.
    Kilian M, Reinholdt J, Mortensen SB, Sørensen CH.
    Bull Eur Physiopathol Respir; 1983; 19(2):99-104. PubMed ID: 6347284
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J, Svennerholm AM.
    Vaccine; 2007 Mar 30; 25(14):2591-8. PubMed ID: 17239498
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Induction of secretory immunity to type 3 Streptococcus pneumoniae by oral immunization.
    Meulbroek JA, Eldridge JH, Alley CD, Michalek SM, McGhee JR.
    Adv Exp Med Biol; 1987 Mar 30; 216B():1765-70. PubMed ID: 3425460
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral immunization induces humoral and cell-mediated immunity and protects germ-free mice against infection from Helicobacter felis.
    Czinn SJ, Cai A, Sellman SP, Nedrud JG.
    Adv Exp Med Biol; 1995 Mar 30; 371B():1645-8. PubMed ID: 7502874
    [No Abstract] [Full Text] [Related]

  • 35. Effect of treatment with nasal IgA on the incidence of infectious disease in world-class canoeists.
    Lindberg K, Berglund B.
    Int J Sports Med; 1996 Apr 30; 17(3):235-8. PubMed ID: 8739580
    [Abstract] [Full Text] [Related]

  • 36. Immunostimulating and protective effects of an oral polybacterial immunomodulator 'Dentavax' in a rabbit experimental model.
    Marinova S, Tchorbadjiiska L, Petrunov B, Cvetanov J, Nenkov P, Konstantinova D, Markova R.
    Int J Immunopharmacol; 2000 Nov 30; 22(11):843-54. PubMed ID: 11090693
    [Abstract] [Full Text] [Related]

  • 37. A predictive model for the level of sIgA based on IgG levels following the oral administration of antigens expressed in Saccharomyces cerevisiae.
    Shin SJ, Shin SW, Choi EJ, Lee DY, Ahn JM, Yang MS, Jang YS, Yoo HS.
    J Vet Sci; 2005 Dec 30; 6(4):305-9. PubMed ID: 16293994
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Oral immunization against mucosal candidiasis in a mouse model.
    Rahman D, Challacombe SJ.
    Adv Exp Med Biol; 1995 Dec 30; 371B():1663-6. PubMed ID: 7502878
    [No Abstract] [Full Text] [Related]

  • 40. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR, Mestecky J.
    Infect Dis Clin North Am; 1990 Jun 30; 4(2):315-41. PubMed ID: 2189002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.